TG Therapeutics Net Total Equity Issued/Repurchased 2010-2025 | TGTX
TG Therapeutics net total equity issued/repurchased for the twelve months ending March 31, 2025 was $-0.016B, a 110.91% decline year-over-year.
- TG Therapeutics annual net total equity issued/repurchased for 2024 was $-0.008B, a 116.4% decline from 2023.
- TG Therapeutics annual net total equity issued/repurchased for 2023 was $0.048B, a 8090.07% increase from 2022.
- TG Therapeutics annual net total equity issued/repurchased for 2022 was $0.001B, a 76.02% decline from 2021.